Shahnaz Miri, Md, Mba

Board-certified neurologist with subspecialty expertise in neuro-ophthalmology and movement disorders. Experienced in high-volume outpatient neurology, inpatient neurology consultation, and acute stroke management. Most recently served as consulting neurologist across multiple Kaiser Permanente Northern California facilities (Oakland, Walnut Creek, Antioch), providing outpatient neurology, inpatient consultation, and inpatient neurology service coverage including telestroke follow-up care.

Maintains an active independent neuro-ophthalmology practice in San Francisco. Prior academic appointments at Johns Hopkins Medicine (Wilmer Eye Institute) and Bascom Palmer Eye Institute. Proficient with Epic EMR.

Consulting Neurologist - Kaiser Permanente Northern California - Oakland, Walnut Creek, Antioch, CA

(2023-01 - 2025-09)

• Provided outpatient general neurology across Oakland, Walnut Creek, and Antioch facilities
• Covered inpatient neurology service and consultation at Antioch Medical Center, including admitted inpatient neurology patients
• Provided inpatient follow-up care for acute stroke patients initially managed via Kaiser telestroke service
• Managed a broad spectrum of neurological conditions in a high-volume integrated health system

Founder & Medical Director - Vision Neurology Center - San Francisco, CA

(2022-10)

Founded and operate an independent outpatient neuro-ophthalmology practice in San Francisco.

• Evaluate and manage the full scope of neuro-ophthalmic disorders including optic neuropathies, IIH, diplopia, and neuro-ophthalmic manifestations of systemic and neurological disease
• Botulinum toxin clinic for blepharospasm, hemifacial spasm, chronic migraine, and cervical dystonia

Adjunct Faculty & Neuro-Ophthalmology Chief - CPMC Residency Program, Sutter Health - San Francisco, CA

(2025-03 - 2026-03)

Neuro-ophthalmology chief for CPMC neurology residency program; clinical teaching and supervision.

Medical Officer, Division of Neuromodulation - U.S. Food and Drug Administration (FDA) — OHT5

(2024-01 - 2025-07)

• Reviewed neurology device submissions spanning brain-implantable and external neuromodulation technologies
• Applied clinical neurology expertise to safety and efficacy review across PMA, De Novo, 510(k), Q-Sub, and Breakthrough Device pathways

Advisor, Catalyst Program - UCSF

(2025-12 - 2026-03)

Advised neurology and neurosurgery faculty on FDA medical device regulatory strategy; both advisees received UCSF Catalyst Awards.

Assistant Professor of Ophthalmology & Neurology - Johns Hopkins Medicine — Wilmer Eye Institute

(2021-07 - 2022-10)

Dual appointment: Division of Neuro-Ophthalmology (Wilmer Eye Institute) and Division of Neuroimmunology and Neurological Infections (Dept. of Neurology). Knights Templar Research Professorship.

• Inpatient and outpatient neuro-ophthalmology; teaching and supervision of ophthalmology residents and neuro-ophthalmology fellows

Clinical Instructor, Ophthalmology - Bascom Palmer Eye Institute — University of Miami

(2020-07 - 2021-07)

Outpatient neuro-ophthalmology clinical instructor; teaching and supervision of ophthalmology residents.

MD - Tehran University of Medical Sciences (2005 - 2013)

MBA - Western Governors University (2018 - 2019)

Research Fellowship - Retinal Biomarkers in Parkinson's Disease - SUNY Downstate Medical Center (2013 - 2015)

Internship - Internal Medicine - MedStar Union Memorial Hospital (2015 - 2016)

Residency - Neurology - NIH-Georgetown University / MedStar Health (2016 - 2019)

Fellowship - Movement Disorders - Georgetown University / MedStar Health (2019 - 2020)

Fellowship - Neuro-Ophthalmology - Bascom Palmer Eye Institute, University of Miami (2020 - 2021)